AbbVie Says FDA Approves Qulipta as Migraine Treatment

By Stephen Nakrosis


AbbVie Inc. on Tuesday said the U.S. Food and Drug Administration approved Qulipta for the preventive treatment of episodic migraine in adults.

The company said... | September 29, 2021

Related Keywords

Michael Severino ,Stephen Nakrosis ,Drug Administration ,Abbvie Inc ,Dow Jones ,Abbvie Inc Stock Exchange ,News ,Information ,Press Release ,Y ,Stephen ,Nakrosis ,Abbvie ,N ,Tuesday ,Aid ,The ,Wood ,End ,Drug ,Administration ,Approved ,Qulipta ,Or ,Preventive ,Treatment ,F ,Episodic ,Migraine ,Ompany Abbv Us00287y1091 ,